Invesco Dorsey Wright Healthcare Momentum ETF (PTH)
| Assets | $286.88M |
| Expense Ratio | 0.60% |
| PE Ratio | 26.92 |
| Shares Out | 4.67M |
| Dividend (ttm) | $1.53 |
| Dividend Yield | 2.52% |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 66.87% |
| Volume | 18,734 |
| Open | 60.98 |
| Previous Close | 61.46 |
| Day's Range | 60.27 - 61.38 |
| 52-Week Low | 39.36 |
| 52-Week High | 64.10 |
| Beta | 0.82 |
| Holdings | 56 |
| Inception Date | Oct 12, 2006 |
About PTH
Fund Home PageThe Invesco Dorsey Wright Healthcare Momentum ETF (PTH) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an index of U.S. healthcare firms selected and weighted by price momentum. PTH was launched on Oct 12, 2006 and is issued by Invesco.
Top 10 Holdings
36.59% of assets| Name | Symbol | Weight |
|---|---|---|
| Revolution Medicines, Inc. | RVMD | 5.19% |
| Roivant Sciences Ltd. | ROIV | 5.06% |
| Guardant Health, Inc. | GH | 4.87% |
| Axsome Therapeutics, Inc. | AXSM | 3.90% |
| BrightSpring Health Services, Inc. | BTSG | 3.87% |
| Oruka Therapeutics, Inc. | ORKA | 2.93% |
| Erasca, Inc. | ERAS | 2.89% |
| Liquidia Corporation | LQDA | 2.71% |
| 10x Genomics, Inc. | TXG | 2.66% |
| Replimune Group, Inc. | REPL | 2.52% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $1.52645 | Dec 26, 2025 |
| Jun 24, 2024 | $0.02545 | Jun 28, 2024 |
| Dec 20, 2013 | $0.01137 | Dec 31, 2013 |
| Sep 20, 2013 | $0.00256 | Sep 30, 2013 |
| Jun 21, 2013 | $0.03682 | Jun 28, 2013 |
| Dec 21, 2012 | $0.10903 | Dec 31, 2012 |
Performance
PTH had a total return of 53.06% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.78%.
News
Best Growth ETFs for Q2 2021
The best growth ETFs for Q2 2021 are OGIG, PTF, and PTH.
Best Healthcare ETFs for Q1 2021
The best healthcare ETFs for Q1 2021 are ARKG, PTH, and KURE.
Specialty biotech funds jump on promising coronavirus, funding news
Specialized health-care exchange-traded funds outperformed the broader stock market Wednesday even as stocks rebounded from a sell-off that left the Nasdaq Composite Index in correction territory. Th...
3 ETFs in Focus as Race for Vaccine Intensifies
Several companies sit at the forefront of developing a coronavirus vaccine. Gain exposure to each using the following three ETFs.